Villasís-Keever MÁ, Rendón-Macías ME, García HJ, Escamilla-Núñez A, Salinas-Escudero G, Martínez-Valverde S, Garduño-Espinosa J, Muñoz-Hernández O

Language: Spanish
References: 31
Page: 477-491
PDF size: 510.13 Kb.

ABSTRACT

Background. In order to evaluate the effectiveness of the bovine surfactant (BS) for the treatment of newborns with respiratory distress syndrome (RDS), we performed a systematic review and meta-analysis.
Methods. Randomized-controlled trials (RCT) assessing the BS in comparison with placebo for the treatment of prematures with RDS were included. Outcome measures evaluated were: mortality, morbidity, days on mechanical ventilation (MV) and length of hospitalization. RCT published until 2010 were obtained from Medline, EMBASE and Cochrane Collaboration. Selection of included studies was based on a peer-review process. For the meta-analyses, relative risk (RR) and weighted mean differences (WMD) were calculated, with 95% confidence intervals (95%CI).
Results. From 865 titles and abstracts obtained, 89 papers were reviewed and 12 RCT were selected. Among the outcome measures assessed, BS was shown to be effective in only in four: mortality (RR 0.73, 95% CI 0.60–0.88, p =0.001), pneumothorax (RR 0.41; 95% CI 0.33–0.51, p ‹0.0001), pulmonary interstitial emphysema (RR 0.45; 95% CI 0.36–0.56, p ‹0.0001) and on days of MV (WMD -9.57; 95% CI -16.58 to -2.56, p =0.007). However, we did not find any positive effect on bronchopulmonary dysplasia, necrotizing enterocolitis, intraventricular hemorrhage or abnormal neurological development.
Conclusions. In newborns with RDS, bovine surfactant is effective regarding mortality, pneumothorax, and pulmonary interstitial emphysema, as well as on decrease in the length of MV and possibly on length of hospitalization.

REFERENCES

1. Sweet D, Bevilacqua G, Carnielli V, Greisen G, Plavka R, Saugstad OD, et al. European consensus guidelines on the management of neonatal respiratory distress syndrome. J Perinat Med 2007;35:175-186.

2. Jobe AH. Lung maturation: the survival miracle of very low birth weight infants. Pediatr Neonatol 2010;51:7-13.

3. Logan JW, Moya FR. Animal-derived surfactants for the treatment and prevention of neonatal respiratory distress syndrome: summary of clinical trials. Ther Clin Risk Manag 2009;5:251-260.

4. Obladen M. History of surfactant up to 1980. Biol Neonate 2005;87:308-316.

5. Halliday HL. History of surfactant from 1980. Biol Neonate 2005;87:317-322.

6. Halliday HL. Surfactants: past, present and future. J Perinatol 2008;28(Suppl 1):S47-S56.

7. Engle WA, American Academy of Pediatrics Committee on Fetus and Newborn. Surfactant-replacement therapy for respiratory distress in the preterm and term neonate. Pediatrics 2008;121:419-432.

8. Kresch MJ, Clive JM. Meta-analyses of surfactant replacement therapy of infants with birth weights less than 2000 grams. J Perinatol 1998;18:276-283.

9. Ramanathan R. Animal-derived surfactants: where are we? The evidence from randomized, controlled clinical trials. J Perinatol 2009;29(Suppl 2):S38-S43.

10. Seger N, Soll R. Animal derived surfactant extract for treatment of respiratory distress syndrome. Cochrane Database Syst Rev 2009;2:CD007836. Available at: http://www2.cochrane.org/reviews/en/ab007836.html

11. Soll R, Özek E. Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome. Cochrane Database Syst Rev 2009;1:CD000141. Available at: http://www2.cochrane.org/reviews/en/ab000141.html

12. Sánchez-Mendiola M, Martínez-Natera OC, Herrera-Maldonado N, Ortega-Arroyo J. Estudio controlado del tratamiento de la enfermedad de membrana hialina del recién nacido pretérmino con surfactante pulmonar exógeno (porcino vs. bovino). Gac Méd Méx 2005;141:267-271.

13. Rojas MA, Lozano JM, Rojas MX, Laughon M, Bose CL, Rondon MA, et al. Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive airway pressure: a randomized, controlled trial. Pediatrics 2009;123:137-142.

14. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1-12.

15. Gitlin JD, Soll RF, Parad RB, Horbar JD, Feldman HA, Lucey JF, et al. Randomized controlled trial of exogenous surfactant for treatment of hyaline membrane disease. Pediatrics 1987;79:31-37.

16. Ware J, Taeusch HW, Soll RF, McCormick MC. Health and developmental outcomes of a surfactant controlled trial: follow-up at 2 years. Pediatrics 1990;85:1103-1107.

17. Raju TN, Vidyasagar D, Bhat R, Sobel D, McCulloch KM, Anderson M, et al. Double-blind controlled trial of single-dose treatment with bovine surfactant in severe hyaline membrane disease. Lancet 1987;21:651-656.

18. Soll RF, Duc G, Minoli T, Vermosld H, Riegel K, Schachinger H. European study of single dose surfactant TA (STA) for treatment of respiratory distress syndrome (RDS). Pediatr Res 1988;23:525A.

19. Horbar JD, Soll RF, Sutherland JM, Kotagal U, Philip AGS, Kessler DL, et al. A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome. N Eng J Med 1989;320:959-965.

20. Horbar JD, Soll RF, Schachinger H, Kewitz G, Versmold HT, Lindner W, et al. A European multicenter randomized controlled trial of single dose surfactant therapy for idiopathic respiratory distress syndrome. Eur J Pediatr 1990;149:416-423.

21. Dunn MS, Shennan A, Possmayer F. Single- versus multiple-dose surfactant replacement therapy in neonates of 30 to 36 weeks’ gestation with respiratory distress syndrome. Pediatrics 1990;86:564-571.

22. Fujiwara T, Konishi M, Chida S, Okuyama K, Ogawa Y, Takeuchi Y, et al. Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome: final analysis of a multicenter, double-blind randomized trial and comparison with similar trials. Pediatrics 1990;86:753-764.

23. Chen JY. Exogenous surfactant for treatment of respiratory distress syndrome in prematures infants. J Formos Med Assoc 1990;89:110-114.

24. Dunn MS, Shennan AT, Zayack D, Possmayer F. Bovine surfactant replacement therapy in neonates of less than 30 weeks’ gestation: a randomized controlled trial of prophylaxis versus treatment. Pediatrics 1991;87:377-396.

25. Liechty EA, Donovan E, Purohit D, Gilhooly J, Feldman B, Noguchi A, et al. Reduction of neonatal mortality after multiple doses of bovine surfactant in low birth weight neonates with respiratory distress syndrome. Pediatrics 1991;88:19-28.

26. Gortner L, Bernsau U, Hellwege HH, Hieronimi G, Jorch G, Reiter HL. A multicenter randomized controlled clinical trial of bovine surfactant for prevention of respiratory distress syndrome. Lung 1990;168(Suppl):864-869.

27. Gortner L, Bartmann P, Pohlandt F, Bernsau U, Porz F, Hellwege HH, et al. Early treatment of respiratory distress syndrome with bovine surfactant in very preterm infants: a multicenter controlled clinical trial. Pediatr Pulmonol 1992;14:4-9.

28. Dani C, Barp J, Berti E, Bertini G. Surfactant in the preterm infant: what’s going on. J Matern Fetal Neonatal Med 2009;22(Suppl 3):3-5.

29. Mugford M. Cost effectiveness of prevention and treatment of neonatal respiratory distress (RDS) with exogenous surfactant: what has changed in the last three decades? Early Hum Dev 2006;82:105-115.

30. Jasso-Gutiérrez L, Mejía-Aranguré JM. Evaluación del tratamiento con surfactante en el síndrome de dificultad respiratoria. El aporte de diferentes metaanálisis. Bol Med Hosp Infant Mex 1998;55:468-476.

31. Moher D, Cook DJ, Jadad AR, Tugwell P, Moher M, Jones A, et al. Assessing the quality of reports of randomized trials: implications for the conduct of meta-analyses. Health Technol Assess 1999;3:1-98.